Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Ondansetron for PONV in Cardiac Surgery
NCT02966041Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by University of British Columbia. Primary endpoint: Occurrence of Post-operative Nausea and Vomiting. Started Mar 2018; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02966041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966041.